Foghorn Therapeutics Inc.

FHTXNASDAQHealthcare● Active

$3.71

$-0.02(-0.54%)

Market Cap$217828569

P/E Ratio—

52W High$6.95

52W Low$3.27

Avg Volume161K

Open$3.67

Beta2.89

Cash on Hand Financials Revenue

Foghorn Therapeutics Inc. (FHTX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

FHTX · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$158.9M▼ -34.8% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$80.9M

cashAndCashEquivalents

Short-Term Investments

$78.0M

shortTermInvestments

YoY Change vs Prior Year

-34.8%

vs prior fiscal year

Latest Quarter

$184.9M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$158.9MCash on Hand

Total Debt$41.3MTotal Debt

Net Cash / Net Debt+$117.6MNet Cash Position

Cash vs Debt Ratio

Cash 79%Foghorn Therapeutics Inc. cash as % of market cap: 72.94%% · MCap $0BDebt 21%

Foghorn Therapeutics Inc. has a net cash position of $117.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$158.9M − $41.3M = +$117.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

FHTX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

FHTX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$158.9M-34.8%

Dec 31, 2024FY$243.7M+4.1%

Dec 31, 2023FY$234.1M-32.3%

Dec 31, 2022FY$345.8M+124.1%

Dec 31, 2021FY$154.3M-16.9%

FHTX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

FHTX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Foghorn Therapeutics Inc.YOU

FHTX

$158.9M$218M72.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Foghorn Therapeutics Inc. (FHTX) cash on hand as of December 31, 2025 is $158.9M, comprising $80.9M in cash and cash equivalents (CCE) plus $78.0M in short-term investments — reported as Foghorn Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Foghorn Therapeutics Inc. cash reserves or cash position.

Foghorn Therapeutics Inc. annual cash on hand history shows decreased -34.8% in 2025: decreased -34.8% in 2025. Foghorn Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Foghorn Therapeutics Inc. carries total debt of $41.3M against cash of $158.9M, resulting in a net cash position of +$117.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

FHTX cash on hand · 5 questions

As of December 31, 2025, Foghorn Therapeutics Inc. (FHTX) has $158,894,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $80,876,000 in cash and cash equivalents (CCE) plus $78,018,000 in short-term investments. Latest quarter (March 31, 2026): $184,881,000. Data sourced from the annual 10-K filing via FMP.

FHTX cash on handFHTX cash reservesFHTX cash 2025how much cash does FHTX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Foghorn Therapeutics Inc. · Foghorn Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025